Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C777425-0.2 0.2 mg (1 mg/ml) $540 
LTA / TNF Beta Antibody - WB on LPS-treated PBM lysate.
LTA / TNF Beta Antibody - WB on LPS-treated PBM lysate.
LTA / TNF Beta Antibody - WB on LPS-treated PBM lysate.
LTA / TNF Beta Antibody - WB on LPS-treated PBM lysate.
1 of 2
2 of 2

Recombinant Monoclonal Rabbit anti‑Human LTA / TNF Beta Antibody (clone 3F12.2D3, Lymphotoxin alpha) LS‑C777425

Recombinant Monoclonal Rabbit anti‑Human LTA / TNF Beta Antibody (clone 3F12.2D3, Lymphotoxin alpha) LS‑C777425

Antibody:
LTA / TNF Beta Rabbit anti-Human Recombinant Monoclonal (Lymphotoxin alpha) (3F12.2D3) Antibody
Application:
Flo, ELISA, Neut, SPR
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$540
LS-C777425-0.2
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
LTA / TNF Beta Rabbit anti-Human Recombinant Monoclonal (Lymphotoxin alpha) (3F12.2D3) Antibody
Application:
Flo, ELISA, Neut, SPR
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
This LTA / TNF Beta antibody is an unconjugated Rabbit/Human chimeric recombinant monoclonal antibody. Validated for ELISA, Flo, Neut, and SPR.
Target
Human LTA / TNF Beta
Synonyms
LTA | Lymphotoxin-alpha | LT-alpha | TNFSF1 | TNF-beta | TNFB | Tumor necrosis factor beta | LT | TNF Beta
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG,k Recombinant Monoclonal
Clone
3F12.2D3
Conjugations
Unconjugated
Purification
Protein A purified
Modifications
Unmodified
Immunogen
3F12 was prepared by hyperimmunizing BALB/c mice with purified recombinant human LTa expressed in E. coli - the hybridoma clone was selected for its ability to bind LTa3 by ELISA. The CDRs of the antibody were grafted to the framework regions of the mice mAb 2G7 to create the chimeric version of the antibody.
Epitope
Lymphotoxin alpha
Specificity
3F12 binds to human LT alpha 3 and LT alpha beta (with a KD of ~0.3 nM, determined by BIACORE; ~ 37 pM, determined by ELISA) in both its soluble homotrimeric and membrane heterotrimeric forms. LT alpha belongs to the tumor necrosis factor (TNF) superfamily and is secreted as a homo-trimer (LT alpha 3), or is expressed on the cell surface in complex with LT beta. Lymphotoxin is produced by lymphocytes and in its homotrimeric form binds to TNFRSF1A/TNFR1, TNFRSF1B/TNFBR and TNFRSF14/HVEM. LT alpha 3 signaling induces target cells to upregulate many chemokines and cytokines in an NFkB-dependent manner.
Applications
  • Flow Cytometry
  • ELISA
  • Neutralization
  • Surface Plasmon Resonance
Usage
Applications should be user optimized.
Presentation
PBS, 0.02% ProClin™ 300.
Storage
Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About LTA / TNF Beta
P01374 NM_000595 NP_000586.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/28/2024